Clinical Trial Update: Phase II Study of Whole or Partial Parotid Sparing Intensity Modulated Radiotherapy in Patients With Head and Neck Cancers

View source ↗

Summary

Phase II study evaluating whole or partial parotid-sparing intensity-modulated radiotherapy in patients with head and neck cancer; the current status is unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Head and Neck Cancer | Status: UNKNOWN